Share >  
Share
Share on Tumblr

Glenmark Generics Ipo

News »

   latest by relevance
Glenmark gets tentative US nod for migraine treatment drug
May 16, 2012 at 12:24 | Source: Moneycontrol.com
Glenmark Pharma's US generics arm has received tentative approval from US Food and Drugs Administration (FDA) for Zolmitriptan orally disintegrating tablets, its copy of AstraZeneca's ZomigZMT tablets.
Glenmark sees 22-25% sales growth, no acquisitions in FY13
May 09, 2012 at 12:08 | Source: Moneycontrol.com
After a strong growth in 2011-12, Glenmark Pharmaceuticals expects to continue strong growth momentum this year too. It expects sales will rise 22-25% (excluding licensing income), helped by new drug launches in the US market and strong growth in most other regions.
Launches in FY13 to boost growth in Indian market: Glenmark
May 09, 2012 at 11:42 | Source: CNBC-TV18
Aided by malarone and cutivate generic, the US business of Glenmark Pharma saw recovery in the fourth quarter of FY12. In an interview with CNBC-TV18, Glenn Saldanha, MD & CEO of Glenmark said, the company expects its domestic market to outperform industry in FY13.
Glenmark gets US FDA nod for generic antiepileptic drug
May 07, 2012 at 14:27 | Source: Moneycontrol.com
Glenmark Phama's arm Glenmark Generics USA has received US Food and Drugs Administration Approval for its abbreviated new drug approval (ANDA) for Lamotrigine Tablets in various strengths.
Glenmark gets US nod for another oral contraceptive generic
Apr 09, 2012 at 11:21 | Source: Moneycontrol.com
Glenmark Pharma's US Generics arm has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) for oral contraceptive Norgestimate and Ethinyl Estradiol tablets 0.25/0.035 mg strength.
Glenmark gets US nod for oral contraceptive Mircette copy
Apr 03, 2012 at 11:22 | Source: Moneycontrol.com
Drug maker Glenmark Pharmaceuticals' US generics arm has received final approval from US Food and Drugs Administration to sell Desogestrel and Ethinyl Estradiol tablets of 0.15 mg/0.02 mg strengths.

Videos »
Launches in FY13 to boost growth in Indian market: Glenmark
Profit down 35%, but topline at record Rs 1055 cr: Glenmark
Glenmark settles patent litigation with Daiichi, Genzyme
Glenmark confident of US growth despite Tarka issue
No plans to list generics biz as of now: Glenmark
more »

Photos »

  /  
Related News »
IPO market in the doldrums: 50 issues of Rs 40,000 cr gone
The secondary market and global liquidity hold key for the future of IPO market. The IPOs called off so far include Reliance Infra Tel, Lodha Developers, AMR Constructions, PNC Infratech, Ambiance, PCI, Ankita Knitwear, Glenmark Generics, Kabirdass Motor ...
May 17, 2012 at 06:26 | Source: moneyguruindia.com

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window